ATOS
Atossa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.52
−0.40%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-140.5%
Return on equity
-116.8%
Return on assets
-146.3%
Return on invested capital
0.00x
Asset turnover
-$35.8M
Cash from operations
$2.61
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026